XRAY DENTSPLY SIRONA Inc.


$ 10.97 $ -0.38 (-3.35 %)    

Thursday, 06-Nov-2025 10:21:37 EST
QQQ $ 617.90 $ -3.82 (-0.63 %)
DIA $ 471.29 $ -0.74 (-0.16 %)
SPY $ 674.93 $ -1.55 (-0.23 %)
TLT $ 89.68 $ 0.12 (0.14 %)
GLD $ 366.91 $ -0.35 (-0.1 %)
$ 12.62
$ 11.35
$ 10.96 x 300
$ 10.97 x 681
$ 10.71 - $ 11.35
$ 11.69 - $ 23.84
3,451,039
na
2.52B
$ 0.88
nm
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 dentsply-sirona-lowers-fy2025-adj-eps-guidance-from-180-200-to-160-vs-188-est-affirms-fy2025-sales-guidance-of-3600b-3700b-vs-3653b-est

Dentsply Sirona (NASDAQ:XRAY) lowers FY2025 Adj EPS guidance from $1.80-$2.00 to $1.60 vs $1.88 analyst estimate. Affirms FY202...

 dentsply-sirona-q3-adj-eps-037-misses-045-estimate-sales-904000m-beat-896710m-estimate

Dentsply Sirona (NASDAQ:XRAY) reported quarterly earnings of $0.37 per share which missed the analyst consensus estimate of $0....

 ubs-maintains-buy-on-dentsply-sirona-lowers-price-target-to-23

UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $24 to $23.

 dentsply-sirona-says-sec-concludes-investigation-of-dentsply-sirona-sec-does-not-recommend-enforcement-action-against-co-sec-has-concluded-its-investigation-of-company-commenced-in-may-2022

On October 14, 2025, DENTSPLY SIRONA Inc. (the "Company") announced that the Division of Enforcement of the Securities ...

 evercore-isi-group-maintains-in-line-on-dentsply-sirona-lowers-price-target-to-13

Evercore ISI Group analyst Elizabeth Anderson maintains Dentsply Sirona (NASDAQ:XRAY) with a In-Line and lowers the price ta...

 forecasting-the-future-5-analyst-projections-for-dentsply-sirona

In the last three months, 5 analysts have published ratings on Dentsply Sirona (NASDAQ: XRAY), offering a diverse range of pers...

 needham-reiterates-hold-on-dentsply-sironato-hold

Needham analyst David Saxon reiterates Dentsply Sirona (NASDAQ: XRAY) from Hold to Hold.

 dentsply-sirona-decides-to-retain-wellspect-healthcare-after-strategic-review

DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company has co...

 ubs-maintains-buy-on-dentsply-sirona-lowers-price-target-to-24

UBS analyst Kevin Caliendo maintains Dentsply Sirona (NASDAQ:XRAY) with a Buy and lowers the price target from $25 to $24.

 barrington-research-maintains-outperform-on-dentsply-sirona-lowers-price-target-to-18

Barrington Research analyst Michael Petusky maintains Dentsply Sirona (NASDAQ:XRAY) with a Outperform and lowers the price t...

 wells-fargo-maintains-equal-weight-on-dentsply-sirona-lowers-price-target-to-15

Wells Fargo analyst Vik Chopra maintains Dentsply Sirona (NASDAQ:XRAY) with a Equal-Weight and lowers the price target from ...

 stifel-maintains-hold-on-dentsply-sirona-lowers-price-target-to-17

Stifel analyst Jonathan Block maintains Dentsply Sirona (NASDAQ:XRAY) with a Hold and lowers the price target from $19 to $17.

 dentsply-sirona-maintains-outlook-despite-sales-decline

Dentsply Sirona beat Q2 EPS and sales forecasts, drove margin expansion and EBITDA growth, reaffirmed FY25 guidance despite mix...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION